Mononucleosis Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1064302
  • May 2021
  • Biotechnology
  • 133 Pages
The Mononucleosis Diagnostic market research report provides an in-depth analysis of the currents trends, latest developments, scenario, market size, various drivers, restraints, and major players along with their profile details. Research report offers the historic data for year 2018 and 2019 and also provides the forecast data from year 2020 to 2028 which is based on revenue (USD Million). With the help of all these information research report helps the market participants to improve market positions. With the help of all these insights Mononucleosis Diagnostic market research report recommends a business strategy for present market participants to strengthen their position in the market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Abbott, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Cardinal Health, Inc., F. Hoffmann-La Roche Ltd, Immunostics Inc., Quidel Corporation, Sekisui Diagnostics, Meridian Bioscience
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Furthermore, the research report includes the detailed information about major players and provides the data regarding the current market scenario as well as upcoming market opportunities or challenges. Similarly, in segment report covers the types, and applications according to the countries and key regions. The research report consists the various drivers and restraints for Mononucleosis Diagnostic market along with their effects over the forecast period. Similarly, according to the region Mononucleosis Diagnostic market research report includes the study of opportunities available in the market situation.

The Mononucleosis Diagnostic market research report provides the in-depth data analysis by using the various graphs, figures, charts, and tables. Furthermore, the report provides the different business challenges which are impacting market growth in all direction.

Major Key Players for Global Mononucleosis Diagnostic Market:
The Mononucleosis Diagnostic market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Abbott, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Cardinal Health, Inc., F. Hoffmann-La Roche Ltd, Immunostics Inc., Quidel Corporation, Sekisui Diagnostics, Meridian Bioscience

Mononucleosis Diagnostic Market Segmentation Analysis:
By Test Type
Epstein Barr Virus
EBV Antibody Test
Complete Blood Count Test
Monospot Test
End User
Hospitals
Laboratories
Other End Users


Global Mononucleosis Diagnostic Market Segmentation by Regions:
In regional analysis, Mononucleosis Diagnostic market research report provides the detailed analysis from various regions and also contains the detailed analysis of country. Along with market revenue, market value report also offers the forecast analysis for the following countries and regions. Global Mononucleosis Diagnostic market report covers the various geographical regions such as North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Also, various countries included are Canada, U.K., France, the U.S., Japan, China, India, and Germany and so on.

North America Region for Mononucleosis Diagnostic Market: Value and Forecast
  • U.S.
  • Canada
 Europe Region for Mononucleosis Diagnostic Market: Value and Forecast
  • UK
  • Germany
  • France
  • Rest of the Europe
 Asia Pacific Region for Mononucleosis Diagnostic Market: Value and Forecast
  • China
  • Japan
  • India
  • Rest of the Asia Pacific
 Latin America Region for Mononucleosis Diagnostic Market: Value and Forecast
  • Mexico
  • Brazil
  • Rest of the Latin America
 Middle East and Africa for Mononucleosis Diagnostic Market: Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Important Points Covered by Report:
  • To analyze the value of the Mononucleosis Diagnostic market, according to the key region.
  • To study the Mononucleosis Diagnostic market current trends, prospects and also their participation in the entire sector.
  • Report consists the in-depth information related to the region/countries, major key players, current trends and their analysis, product type, applications, and other background information
  • Report provides the detailed information about drivers, restraints and future scope of Mononucleosis Diagnostic market.
  • Report covers the information about historic data analysis as well as forecast period analysis.

Global Mononucleosis Diagnostic research report consist the information about overall sales and revenue during the historic and forecasted period of 2018 to 2028. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Mononucleosis Diagnostic market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Mononucleosis Diagnostic market for numerous purposes such as:

    1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Mononucleosis Diagnostic market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Mononucleosis Diagnostic market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Mononucleosis Diagnostic market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Abbott
  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Cardinal Health, Inc.
  • F. Hoffmann-La Roche Ltd
  • Immunostics Inc.
  • Quidel Corporation
  • Sekisui Diagnostics
  • Meridian Bioscience
  • Epstein Barr Virus
  • EBV
  • End UserEnd Users

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Mononucleosis Diagnostic Market Snapshot
          2.1.1. Global Mononucleosis Diagnostic Market By Test Type,2019
               2.1.1.1.Epstein Barr Virus
               2.1.1.2.EBV
          2.1.2. Global Mononucleosis Diagnostic Market By End UserEnd Users,2019
               2.1.2.1.End UserEnd Users
          2.1.3. Global Mononucleosis Diagnostic Market By End-use,2019
          2.1.4. Global Mononucleosis Diagnostic Market By Geography,2019

3. Global Mononucleosis Diagnostic Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Mononucleosis Diagnostic Market Size (US$), By Test Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Test Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Test Type, 2020
     4.2. Global Mononucleosis Diagnostic Market Size (US$), By Test Type, 2018 – 2028

5. Global Mononucleosis Diagnostic Market Size (US$), By End UserEnd Users, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End UserEnd Users, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End UserEnd Users, 2020
     5.2. Global Mononucleosis Diagnostic Market Size (US$), By End UserEnd Users, 2018 – 2028

6. Global Mononucleosis Diagnostic Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Mononucleosis Diagnostic Market Size (US$), By End-use, 2018 – 2028

7. Global Mononucleosis Diagnostic Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Mononucleosis Diagnostic Market Analysis, 2018 – 2028 
          7.2.1. North America Mononucleosis Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Mononucleosis Diagnostic Market Size (US$), By Test Type, 2018 – 2028
          7.2.3. North America Mononucleosis Diagnostic Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.2.4. North America Mononucleosis Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Mononucleosis Diagnostic Market Analysis, 2018 – 2028 
          7.3.1.  Europe Mononucleosis Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Mononucleosis Diagnostic Market Size (US$), By Test Type, 2018 – 2028
          7.3.3. Europe Mononucleosis Diagnostic Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.3.4. Europe Mononucleosis Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Mononucleosis Diagnostic Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Mononucleosis Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Mononucleosis Diagnostic Market Size (US$), By Test Type, 2018 – 2028
          7.4.3. Asia Pacific Mononucleosis Diagnostic Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.4.4. Asia Pacific Mononucleosis Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Mononucleosis Diagnostic Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Mononucleosis Diagnostic Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Mononucleosis Diagnostic Market Size (US$), By Test Type, 2018 – 2028
          7.5.3. Latin America Mononucleosis Diagnostic Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.5.4. Latin America Mononucleosis Diagnostic Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Mononucleosis Diagnostic Market Analysis, 2018 – 2028 
          7.6.1.  MEA Mononucleosis Diagnostic Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Mononucleosis Diagnostic Market Size (US$), By Test Type, 2018 – 2028
          7.6.3. MEA Mononucleosis Diagnostic Market Size (US$), By End UserEnd Users, 2018 – 2028
          7.6.4. MEA Mononucleosis Diagnostic Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Mononucleosis Diagnostic Providers
        8.4.1 Abbott
                8.4.1.1 Business Description
                8.4.1.2 Abbott Geographic Operations
                8.4.1.3 Abbott Financial Information
                8.4.1.4 Abbott Product Positions/Portfolio
                8.4.1.5 Abbott Key Developments
        8.4.2 Bio-Rad Laboratories, Inc.
                8.4.2.1 Business Description
                8.4.2.2 Bio-Rad Laboratories, Inc. Geographic Operations
                8.4.2.3 Bio-Rad Laboratories, Inc. Financial Information
                8.4.2.4 Bio-Rad Laboratories, Inc. Product Positions/Portfolio
                8.4.2.5 Bio-Rad Laboratories, Inc. Key Developments
        8.4.3 Thermo Fisher Scientific Inc.
                8.4.3.1 Business Description
                8.4.3.2 Thermo Fisher Scientific Inc. Geographic Operations
                8.4.3.3 Thermo Fisher Scientific Inc. Financial Information
                8.4.3.4 Thermo Fisher Scientific Inc. Product Positions/Portfolio
                8.4.3.5 Thermo Fisher Scientific Inc. Key Developments
        8.4.4 Danaher Corporation
                8.4.4.1 Business Description
                8.4.4.2 Danaher Corporation Geographic Operations
                8.4.4.3 Danaher Corporation Financial Information
                8.4.4.4 Danaher Corporation Product Positions/Portfolio
                8.4.4.5 Danaher Corporation Key Developments
        8.4.5 Cardinal Health, Inc.
                8.4.5.1 Business Description
                8.4.5.2 Cardinal Health, Inc. Geographic Operations
                8.4.5.3 Cardinal Health, Inc. Financial Information
                8.4.5.4 Cardinal Health, Inc. Product Positions/Portfolio
                8.4.5.5 Cardinal Health, Inc. Key Developments
        8.4.6 F. Hoffmann-La Roche Ltd
                8.4.6.1 Business Description
                8.4.6.2 F. Hoffmann-La Roche Ltd Geographic Operations
                8.4.6.3 F. Hoffmann-La Roche Ltd Financial Information
                8.4.6.4 F. Hoffmann-La Roche Ltd Product Positions/Portfolio
                8.4.6.5 F. Hoffmann-La Roche Ltd Key Developments
        8.4.7 Immunostics Inc.
                8.4.7.1 Business Description
                8.4.7.2 Immunostics Inc. Geographic Operations
                8.4.7.3 Immunostics Inc. Financial Information
                8.4.7.4 Immunostics Inc. Product Positions/Portfolio
                8.4.7.5 Immunostics Inc. Key Developments
        8.4.8 Quidel Corporation
                8.4.8.1 Business Description
                8.4.8.2 Quidel Corporation Geographic Operations
                8.4.8.3 Quidel Corporation Financial Information
                8.4.8.4 Quidel Corporation Product Positions/Portfolio
                8.4.8.5 Quidel Corporation Key Developments
        8.4.9 Sekisui Diagnostics
                8.4.9.1 Business Description
                8.4.9.2 Sekisui Diagnostics Geographic Operations
                8.4.9.3 Sekisui Diagnostics Financial Information
                8.4.9.4 Sekisui Diagnostics Product Positions/Portfolio
                8.4.9.5 Sekisui Diagnostics Key Developments
        8.4.10 Meridian Bioscience
                8.4.10.1 Business Description
                8.4.10.2 Meridian Bioscience Geographic Operations
                8.4.10.3 Meridian Bioscience Financial Information
                8.4.10.4 Meridian Bioscience Product Positions/Portfolio
                8.4.10.5 Meridian Bioscience Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Mononucleosis Diagnostic Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Mononucleosis Diagnostic Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Mononucleosis Diagnostic Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Mononucleosis Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Mononucleosis Diagnostic Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Mononucleosis Diagnostic Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Mononucleosis Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Mononucleosis Diagnostic Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Mononucleosis Diagnostic Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Mononucleosis Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Mononucleosis Diagnostic Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Mononucleosis Diagnostic Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Mononucleosis Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Mononucleosis Diagnostic Market Revenue, By Test Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Mononucleosis Diagnostic Market Revenue, By End UserEnd Users, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Mononucleosis Diagnostic Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Mononucleosis Diagnostic: Market Segmentation 
FIG. 2 Global Mononucleosis Diagnostic Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Mononucleosis Diagnostic Market, By Test Type, 2019 (US$ Mn) 
FIG. 5 Global Mononucleosis Diagnostic Market, By End UserEnd Users, 2019 (US$ Mn) 
FIG. 6 Global Mononucleosis Diagnostic Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Mononucleosis Diagnostic Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Mononucleosis Diagnostic Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Mononucleosis Diagnostic Providers, 2019
FIG. 11 Global Mononucleosis Diagnostic Market Revenue Contribution, By Test Type, 2019 & 2028 (Value %) 
FIG. 12 Global Mononucleosis Diagnostic Market Revenue Contribution, By End UserEnd Users, 2019 & 2028 (Value %) 
FIG. 13 Global Mononucleosis Diagnostic Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Mononucleosis Diagnostic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Mononucleosis Diagnostic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Mononucleosis Diagnostic Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Mononucleosis Diagnostic Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Mononucleosis Diagnostic Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Mononucleosis Diagnostic market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Mononucleosis Diagnostic Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Mononucleosis Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  North America Mononucleosis Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  North America Mononucleosis Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Europe Mononucleosis Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  Europe Mononucleosis Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  Europe Mononucleosis Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Mononucleosis Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Mononucleosis Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Mononucleosis Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Latin America Mononucleosis Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Mononucleosis Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Mononucleosis Diagnostic Market Value, By Country, 2018 – 2028
TABLE  MEA Mononucleosis Diagnostic Market Value, By Segment1, 2018 – 2028
TABLE  MEA Mononucleosis Diagnostic Market Value, By Segment2, 2018 – 2028
TABLE  MEA Mononucleosis Diagnostic Market Value, By Country, 2018 – 2028
TABLE  Abbott: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Thermo Fisher Scientific Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Danaher Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cardinal Health, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  F. Hoffmann-La Roche Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Immunostics Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Quidel Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sekisui Diagnostics: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Meridian Bioscience: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Mononucleosis Diagnostic Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Mononucleosis Diagnostic Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Mononucleosis Diagnostic Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Mononucleosis Diagnostic Market, By Geography, 2019 (US$ Mn)
FIG.  Global Mononucleosis Diagnostic Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Mononucleosis Diagnostic Providers, 2016
FIG.  Global Mononucleosis Diagnostic Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global EBV Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Mononucleosis Diagnostic Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Mononucleosis Diagnostic Market Value, 2018 – 2028, (US$ Mn)